Bevacizumab for retinopathy of prematurity

N Engl J Med. 2011 Feb 17;364(7):677-8. doi: 10.1056/NEJMe1100248.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Angiogenesis Inhibitors / therapeutic use*
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Bevacizumab
  • Humans
  • Infant, Newborn
  • Infant, Premature
  • Intravitreal Injections
  • Laser Therapy* / adverse effects
  • Recurrence
  • Retina / pathology
  • Retinopathy of Prematurity / drug therapy*
  • Retinopathy of Prematurity / therapy

Substances

  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Bevacizumab